Merck begins construction of $3 billion manufacturing facility in Virginia-March 2024-www.financetom.com

Merck begins construction of $3 billion manufacturing facility in Virginia

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Merck begins construction of $3 billion manufacturing facility in Virginia

Oct 20, 2025 4:30 AM

Oct 20 (Reuters) - Merck ( MRK ) said on Monday it has

begun construction of a $3 billion pharmaceutical manufacturing

facility in Elkton, Virginia as part of its more than $70

billion investment to expand domestic manufacturing and research

and development in the U.S.

Previous page： General Motors Shares Are Rising Today: What's Going On? Next page： Apellis Pharmaceuticals Insider Sold Shares Worth $412,296, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

General Motors Shares Are Rising Today: What's Going On?

Jan 23, 2025

General Motors Co. ( GM ) shares are trading higher Thursday on reports the company and Hyundai are forging an EV partnership for North America. What To Know: Hyundai has confirmed ongoing talks to supply commercial electric vehicles to GM as part of a broader collaboration that includes parts procurement and passenger vehicle cooperation, according to Reuters. The companies reportedly...

Apellis Pharmaceuticals Insider Sold Shares Worth $412,296, According to a Recent SEC Filing

Jan 23, 2025

03:32 PM EST, 01/23/2025 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on January 22, 2025, sold 13,551 shares in Apellis Pharmaceuticals ( APLS ) for $412,296. Following the Form 4 filing with the SEC, Francois has control over a total of 1,957,941 shares of the company, with 418,519 shares held directly and 1,539,422 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760225001837/xslF345X05/form4.xml...

UnitedHealth taps Medicare head as CEO of insurance business

Jan 23, 2025

Jan 23 (Reuters) - UnitedHealth Group ( UNH ) said on Thursday it has appointed Tim Noel, the head of its Medicare business, to replace late CEO Brian Thompson as the head of its insurance unit. (Reporting by Mariam Sunny in Bengaluru) ...

Tiziana Life Sciences' Foralumab Demonstrates Motor Function Improvement in Preclinical Spinal Cord Injury Studies

Jan 23, 2025

03:30 PM EST, 01/23/2025 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Thursday that preclinical studies of foralumab, a nasal anti-CD3 monoclonal antibody, in traumatic spinal cord injury showed notable improvements in motor functions. The company said it is also evaluating the drug candidate in a phase 2a study for patients with non-active secondary progressive multiple sclerosis. Shares...